Product Information
COARTEM TABLETS is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $5.3628 per EA under NDC 00078056845. Its NADAC has been published 197 times since Feb 17, 2016.
FDA first approved this application on Apr 7, 2009.
Strength
20; 120 mg/1; mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078056845
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
ARTEMETHER; LUMEFANTRINEApproval Type
New Drug (NDA)
FDA Application
NDA022268FDA Approved
4/7/2009
On Market Since
4/7/2009
Pharmacological Classes
Price Statistics
The NADAC for COARTEM TABLETS has been published 197 times since Feb 17, 2016, and over the history we have for it it has risen 18.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.3628 per EA |
|---|---|
| All-time high | $5.4007 (Oct 16, 2024) |
| All-time low | $4.5126 (Feb 17, 2016) |
| 52-week high | $5.3679 |
| 52-week low | $5.3521 |
| Median price | $5.3628 |
| Average price | $5.1677 |
| Largest weekly change | +9.9% (Jul 20, 2016) |
| Weeks tracked | 197 |
| Tracking since | Feb 17, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the artemether and lumefantrine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of COARTEM TABLETS?
The current National Average Drug Acquisition Cost (NADAC) for COARTEM TABLETS, manufactured by Novartis Pharmaceuticals Corporation, is $5.3628 per EA (NDC 00078056845), effective Aug 19, 2026.
How has the price of COARTEM TABLETS changed over time?
Over the history we have for it, the NADAC for COARTEM TABLETS has risen 18.8%. It has been tracked across 197 weekly CMS publications since Feb 17, 2016.
What are the highest and lowest recorded NADAC prices for COARTEM TABLETS?
Since Feb 17, 2016, the NADAC for COARTEM TABLETS has ranged from a low of $4.5126 (Feb 17, 2016) to a high of $5.4007 (Oct 16, 2024), with a median of $5.3628 per EA.
Are there cheaper alternatives to COARTEM TABLETS?
No other NADAC-published product currently shares the active ingredient and strength of COARTEM TABLETS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COARTEM TABLETS?
COARTEM TABLETS (NDC 00078056845) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.